This article characterizes the activities required to launch a new
pharmaceutical molecule into the market, summarizes studies that have…
The pricing of medical products and services in the U.S. is notoriously complex. In health
care, supply prices (those received by the…
The U.S. pharmaceutical industry has experienced in recent years two dramatic changes: stagnation in the growth of new molecular entities…
States have banned smoking in workplaces, restaurants, and bars. They have increased tobacco tax rates, extended “clean air” laws, and…
Although US health care expenditures reached 17.6 percent of GDP in 2009, quality measurement in this important service sector remains…
Little is known about the relationship between variation in drug and non-drug medical treatment and how areas may substitute one type of…
Objective: To examine the impact of incentive formularies on prescription drug utilization and spending after introduction of new pharmacy…
Following an acrimonious healthcare reform debate involving charges of "death panels," in 2010, Congress explicitly forbade the use of cost…
Recently, the Centers for Medicaid and Medicare Services announced a scheduled cut in Medicare physician fees of 27.4% for 2012. This cut…